Predicting Coronavirus Disease 2019 Infection Risk and Related Risk Drivers in Nursing Homes: A Machine Learning Approach

被引:29
|
作者
Sun, Christopher L. F. [1 ,2 ]
Zuccarelli, Eugenio [1 ,3 ]
Zerhouni, El Ghali A. [1 ,3 ]
Lee, Jason [1 ,4 ]
Muller, James [5 ]
Scott, Karen M. [1 ]
Lujan, Alida M. [1 ]
Levi, Retsef [1 ]
机构
[1] MIT, Sloan Sch Management, 100 Main St,Room E62-562, Cambridge, MA 02142 USA
[2] Massachusetts Gen Hosp, Healthcare Syst Engn, Boston, MA 02114 USA
[3] MIT, Operat Res Ctr, Cambridge, MA 02142 USA
[4] MIT, Sch Engn, Cambridge, MA 02142 USA
[5] Muller Consulting & Data Analyt LLC, Washington, DC USA
基金
加拿大健康研究院;
关键词
Nursing homes; COVID-19; infection prevention; health policy; long-term care facility; risk modeling; machine-learning; COVID-19; DISPARITIES; QUALITY;
D O I
10.1016/j.jamda.2020.08.030
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: Inform coronavirus disease 2019 (COVID-19) infection prevention measures by identifying and assessing risk and possible vectors of infection in nursing homes (NHs) using a machine-learning approach. Design: This retrospective cohort study used a gradient boosting algorithm to evaluate risk of COVID-19 infection (ie, presence of at least 1 confirmed COVID-19 resident) in NHs. Setting and Participants: The model was trained on outcomes from 1146 NHs in Massachusetts, Georgia, and New Jersey, reporting COVID-19 case data on April 20, 2020. Risk indices generated from the model using data from May 4 were prospectively validated against outcomes reported on May 11 from 1021 NHs in California. Methods: Model features, pertaining to facility and community characteristics, were obtained from a self-constructed dataset based on multiple public and private sources. The model was assessed via out-of-sample area under the receiver operating characteristic curve (AUC), sensitivity, and specificity in the training (via 10-fold cross-validation) and validation datasets. Results: The mean AUC, sensitivity, and specificity of the model over 10-fold cross-validation were 0.729 [95% confidence interval (CI) 0.690.0.767], 0.670 (95% CI 0.477.0.862), and 0.611 (95% CI 0.412-0.809), respectively. Prospective out-of-sample validation yielded similar performance measures (AUC 0.721; sensitivity 0.622; specificity 0.713). The strongest predictors of COVID-19 infection were identified as the NH's county's infection rate and the number of separate units in the NH; other predictors included the county's population density, historical Centers of Medicare and Medicaid Services cited health deficiencies, and the NH's resident density (in persons per 1000 square feet). In addition, the NH's historical percentage of non-Hispanic white residents was identified as a protective factor. Conclusions and Implications: A machine-learning model can help quantify and predict NH infection risk. The identified risk factors support the early identification and management of presymptomatic and asymptomatic individuals (eg, staff) entering the NH from the surrounding community and the development of financially sustainable staff testing initiatives in preventing COVID-19 infection. (C) 2020 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:1533 / +
页数:12
相关论文
共 50 条
  • [41] Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications
    Derosa, Giuseppe
    Maffioli, Pamela
    D'Angelo, Angela
    Di Pierro, Francesco
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [42] Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank
    Topless, Ruth K.
    Phipps-Green, Amanda
    Leask, Megan
    Dalbeth, Nicola
    Stamp, Lisa K.
    Robinson, Philip C.
    Merriman, Tony R.
    ACR OPEN RHEUMATOLOGY, 2021, 3 (05) : 333 - 340
  • [43] At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease
    Cascino, Thomas M.
    Desai, Ankit A.
    Kanthi, Yogendra
    CURRENT OPINION IN PULMONARY MEDICINE, 2021, 27 (05) : 342 - 349
  • [44] Risk Factors Associated with Coronavirus Disease 2019-Related Hospitalization in Rheumatoid Arthritis Patients
    Stojanovic, Sonja
    Stamenkovic, Bojana
    Nedovic, Jovan
    Aleksic, Ivana
    Jovanovic, Jelena
    Cvetkovic, Jovana
    Jocic, Jasmina
    Sarac, Miljana
    Dimic, Novica
    Apostolovic, Marija Andjelkovic
    Stojanovic, Milovan
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (04) : 807 - 814
  • [45] Predicting Future Driving Risk of Crash-Involved Drivers Based on a Systematic Machine Learning Framework
    Wang, Chen
    Liu, Lin
    Xu, Chengcheng
    Lv, Weitao
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (03)
  • [46] Machine Learning Model Predicting Bleeding Risk in Patients With Coronary Artery Disease
    Ishii, Masanobu
    Nakamura, Taishi
    Yamanouchi, Yoshinori
    Otsuka, Yasuhiro
    Ikebe, Sou
    Tsujita, Kenichi
    CIRCULATION, 2023, 148
  • [47] Prediction of Work-Related Risk Factors among Bus Drivers Using Machine Learning
    Hanumegowda, Pradeep Kumar
    Gnanasekaran, Sakthivel
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (22)
  • [48] Coronavirus Disease 2019 Vaccination for Cancer Patients: Risk or Benefit?
    Laporte, Bruno Eduardo Pereira
    Laporte, Estela Gelain Junges
    Aarestrup, Paula Fonseca
    Aarestrup, Matheus Fonseca
    Aarestrup, Fernando Monteiro
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2022, 44 (06): : 602 - 608
  • [49] Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
    Wiemken, Timothy L.
    McGrath, Leah J.
    Andersen, Kathleen M.
    Khan, Farid
    Malhotra, Deepa
    Alfred, Tamuno
    Nguyen, Jennifer L.
    Puzniak, Laura
    Thoburn, Elizabeth
    Jodar, Luis
    McLaughlin, John M.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E42 - E50
  • [50] Examining Attenuated Responses to Coronavirus Disease-2019 Risk
    Choi, Minhee
    O'Donnell, Nicole
    Moon, Won-Ki
    HEALTH EDUCATION & BEHAVIOR, 2024, 51 (06) : 834 - 842